Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Endocrinology
Disease Category: High Cholesterol (Hyperlipidemia)
Trial Information
A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk and not Adequately Controlled with Atorvastatin 20 mg: A Comparison of Switching to a Combination Tablet Ezetimibe/Simvastatin (10mg/40mg) versus Doubling the Baseline Dose to Atorvastatin 40 mg
The purpose of this study is to determine the safety and effectiveness of Vytorin versus Lipitor in subjects with high cholesterol and high cardiovascular risks
Patient Inclusion Criteria:
- Diagnosis of high cholesterol
- Diagnosis of coronary heart disease or considered high risk
Patient Exclusion Criteria: Uncontrolled high blood pressure
Carolinas Research Associates
4315 Physicians Blvd.
Harrisburg, NC 28075
Phone: 704-366-3001
EMail: contact@carolinasresearch.com
View Google Map
Research Center Information: Carolinas Research Associates
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
